Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

Completed · Phase 3

Conditions studied: Pneumococcal Disease, 13-valent Pneumococcal Vaccine

In brief

This study is to evaluate the safety, immunogenicity and impact of 13-valent Pneumococcal conjugate vaccine in Alaskan Native Children.

Key facts

Study ID

NCT00743652

Run by

Pfizer

People needed

373

Starts

2009-01-01

Expected to finish

2010-09-01

Last updated by the study team

2012-03-15

Who can join

Age: 0 and older, up to 5. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female infants 6 weeks to < 5years of age in good health, available for the entire study period and reachable by phone, parents able to complete all relevant study procedures.
• Infants who have received Prevnar are eligible to participate, but this is not required.
• Infants participating in the blood draws must live in a specific identified area (Yukon Kuskokwim Delta region)

You may not qualify if…

• Contraindication to vaccination with pneumococcal vaccine or allergic reaction to any vaccines or vaccine related components, immune deficiency, bleeding disorder or major known congenital malformation.

Where it is running

• Pfizer Investigational Site — Akiak, Alaska, United States
• Pfizer Investigational Site — Bethel, Alaska, United States
• Pfizer Investigational Site — Chefornak, Alaska, United States
• Pfizer Investigational Site — Chevak, Alaska, United States
• Pfizer Investigational Site — Eek, Alaska, United States
• Pfizer Investigational Site — Emmonak, Alaska, United States
• Pfizer Investigational Site — Hooper Bay, Alaska, United States
• Pfizer Investigational Site — Kalskag, Alaska, United States
• Pfizer Investigational Site — Kasigluk, Alaska, United States
• Pfizer Investigational Site — Kongiganak, Alaska, United States
• Pfizer Investigational Site — Kotlik, Alaska, United States
• Pfizer Investigational Site — Kwethluk, Alaska, United States
• Pfizer Investigational Site — Kwigillingok, Alaska, United States
• Pfizer Investigational Site — Mountain Village, Alaska, United States
• Pfizer Investigational Site — Napaskiak, Alaska, United States
• Pfizer Investigational Site — Newtok, Alaska, United States
• Pfizer Investigational Site — Nunapitchuk, Alaska, United States
• Pfizer Investigational Site — Russian Mission, Alaska, United States
• Pfizer Investigational Site — Scammon Bay, Alaska, United States
• Pfizer Investigational Site — Toksook Bay, Alaska, United States
• Pfizer Investigational Site — Tuluksak, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.